✦ LIBER ✦

Comparison of Viral replication fitness of wild-type and lamivudine-resistant HBV in patients

✍ Scribed by Iv, William Delaney; Westland, Christopher; Yang, Huiling; Namini, Hamid; Thibault, Vincent; Benhamou, Yves; Brosgart, Carol; Gibbs, Craig; Miller, Michael; Xiong, Shelly

Book ID: 123181340
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 252 KB
Volume: 124
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(03)83582-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of viral replication fitness

Comparison of viral replication fitness of wild-type and lamivudine-resistant HBV in patients

✍ W.E. Delaney IV; C. Westland; H. Yang; H. Namini; V. Thibault; Y. Benhamou; J. F 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 319 KB

Quantification of the relative levels of

Quantification of the relative levels of wild-type and lamivudine-resistant mutant virus in serum of HBV-infected patients using microarray

✍ Z. G. Li; L. Y. Chen; J. Huang; P. Qiao; J. M. Qiu; S. Q. Wang 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

Wild type and YMDD variant of hepatitis

Wild type and YMDD variant of hepatitis B virus: No difference in viral kinetics on lamivudine/tenofovir therapy in HIV–HBV co-infected patients

✍ T.E.M.S. de Vries-Sluijs; A.A. van der Eijk; B.E. Hansen; A.D.M.E. Osterhaus; R. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 169 KB

684 IS VIRAL LOAD AT WEEK 48 PREDICTIVE

684 IS VIRAL LOAD AT WEEK 48 PREDICTIVE OF ADEFOVIR RESISTANCE IN HBV PATIENTS RECEIVING ADEFOVIR FOR LAMIVUDINE RESISTANCE?

✍ H. Castel; C. Osiowy; E.J. Heathcote; B. Willems; J.P. Villeneuve 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Changes in viral loads of lamivudine-res

Changes in viral loads of lamivudine-resistant mutants and evolution of HBV sequences during adefovir dipivoxil therapy

✍ Fumitaka Suzuki; Hiromitsu Kumada; Hirotoshi Nakamura 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 1 views

The addition of adefovir dipivoxil (ADV) to ongoing lamivudine therapy is effective against lamivudine-resistant virus in patients with hepatitis B virus (HBV) infection. We studied 39 patients who received ADV added to lamivudine for breakthrough hepatitis. We determined early viral changes (12 wee

Emergence of adefovir-resistant mutants

Emergence of adefovir-resistant mutants after reversion to YMDD wild-type in lamivudine-resistant patients receiving adefovir monotherapy

✍ Hyeok Choon Kwon; Jae Youn Cheong; Sung Won Cho; Jae Myoung Choi; Sun Pyo Hong; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB